A randomized phase III trial of biochemotherapy versus interferon-α- 2b for adjuvant therapy in patients at high risk for melanoma recurrence

Kevin B. Kim, Sewa S. Legha, Rene Gonzalez, Clay M. Anderson, Marcella M. Johnson, Ping Liu, Nicholas E. Papadopoulos, Omar Eton, Carl Plager, Antonio C. Buzaid, Victor G. Prieto, Wen Jen Hwu, Angela M. Frost, Gladys Alvarado, Patrick Hwu, Merrick I. Ross, Jeffrey E. Gershenwald, Jeffrey E. Lee, Paul F. Mansfield, Robert S. BenjaminAgop Y. Bedikian

Research output: Contribution to journal › Article › peer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized phase III trial of biochemotherapy versus interferon-α- 2b for adjuvant therapy in patients at high risk for melanoma recurrence'. Together they form a unique fingerprint.

Medicine & Life Sciences